Generation of female genital tract antibody responses by local or central (common) mucosal immunization

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5539-5545

  Wu, H Y ^a   Abdu, S ^a   Stinson, D ^a   Russell, M W ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; DRUG EFFICACY; FEMALE; FEMALE GENITAL SYSTEM; IMMUNE SYSTEM; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALIVA LEVEL;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, INTRAVAGINAL; ANIMAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHOLERA TOXIN; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; SALIVA; STREPTOCOCCUS MUTANS; SUPPORT, U.S. GOV'T, P.H.S.; VAGINA;

EID: 0033801174     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5539-5545.2000     Document Type: Article

References (54)

1. Mucosal immune defense against HIV-1 in the male urogenital tract
2. Human male genital tract immunity and experimental models
3. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection
4. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection
5. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
6. Mucosal immunity in the female genital tract
7. Regional specialization in the mucosal immune system: What happens in the microcompartments?
8. Lymphocyte homing and intestinal immunity
9. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion
10. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues
11. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant
12. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination
13. Specific immune responses in humans following rectal delivery of live typhoid vaccine
14. Specific secrutory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus
15. Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics
16. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits
17. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
18. Limited local and systemic antibody responses to Neissena gonorrhoeae during uncomplicated genital infections
19. Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium
20. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
21. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: Evidence for compartmentalization within the common mucosal immune system in humans
22. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions
23. Mucosal immunity in the human female reproductive tract
24. IgA immunity in female reproductive tract secretions
25. Secretory immunity in the female reproductive tract
26. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation
27. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle
28. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration
29. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit
30. Concept of the local and common mucosal immune response
31. Compartmentalization within the mucosal immune system
32. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain
33. Local antibody response to polio vaccine in the female genital tract
34. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge
35. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2
36. Urethral glands of the male mouse contain secretory component and immunoglobulin A plasma cells and are targets of testosterone
37. Human urethral epithelium: Immunohistochemical demonstration of secretory IgA
38. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues
39. Immunobiology of the human penile urethra
40. Protein antigens of Streptococcus mutans: Purification and properties of a double antigen and its protease-resistant component
41. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and cholera toxin B subunit
42. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit
43. Mucosal immunity to HIV-1. Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A)
44. Local intravaginal vaccination of the female genital tract
45. + CTL activity within the human female reproductive tract. Influence of stage of the menstrual cycle and menopause
46. Mucosal immunity in the human female reproductive tract: Cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women
47. Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits
48. The mucosal immune system in the female reproductive tract: Influence of sex hormones and cytokines on immune recognition and responses to antigen
49. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site
50. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization
51. Induction of antibody-secreting cells and T helper and memory cells in murine nasal lymphoid tissue
52. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit
53. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
54. + T cell-rich lymphoid aggregates in human uterine endometrium